Edwards Lifesciences Says Cooperating With EU Antitrust Regulators After Last Week's Raid; Edwards Lifesciences Says Committed To Healthy Fair Competition, Remains Confident In Its Business Practices
Portfolio Pulse from Benzinga Newsdesk
Edwards Lifesciences is cooperating with EU antitrust regulators following a raid last week. The company remains confident in its business practices and is committed to fair competition.
September 26, 2023 | 3:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Edwards Lifesciences is under scrutiny by EU antitrust regulators, which could potentially impact its business operations.
The investigation by EU antitrust regulators could potentially lead to fines or changes in business practices if Edwards Lifesciences is found to be in violation. This could negatively impact the company's operations and financial performance.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
The ETF VGK, which includes Edwards Lifesciences among its holdings, could be indirectly affected by the EU antitrust investigation.
As Edwards Lifesciences is part of the VGK ETF, any negative impact on Edwards Lifesciences due to the EU antitrust investigation could indirectly affect the ETF's performance.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 50